The hepatorenal syndrome.
A new appreciation of the hemodynamic, hormonal, and neural derangements associated with unexplained renal failure in patients with severe liver disease has led to a reappraisal of the limited therapeutic approaches to the hepatorenal syndrome. Although the prognosis generally remains dismal, specific supportive measures are now available for the management of selected patients.
Epstein
M
M
University of Miami School of Medicine.
D009320:Atrial Natriuretic Factor / Q000172:deficiency; D003937:Diagnosis, Differential; D006439:Hemodynamics; D006530:Hepatorenal Syndrome / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007101:Immersion; D007674:Kidney Diseases / Q000628:therapy*; D008103:Liver Cirrhosis / Q000150:complications; D011379:Prognosis; D012079:Renal Circulation; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014511:Uremia / Q000175:diagnosis
D009320:Atrial Natriuretic Factor